Current and historical daily PE Ratio for CSPCY (
CSPC Pharmaceutical Group Ltd
) from 2018 to Aug 13 2026. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. CSPC Pharmaceutical Group stock (CSPCY) PE ratio as of Aug 13 2026 is 27.92.
More Details
CSPC Pharmaceutical Group Ltd (CSPCY) PE Ratio (TTM) Chart
CSPC Pharmaceutical Group Ltd (CSPCY) PE Ratio (TTM) Historical Data
View and export this data going back to 2018. Start your Free Trial
Total 1224
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| CSPC Pharmaceutical Group PE Ratio (TTM) Historical Data | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data | ||||||
| 2026-08-13 | 27.2 | 27.16 | 27.16 | 27.16 | 2026-06-09 | 21.9 | 21.91 | 21.79 | 21.91 |
| 2026-08-12 | 27.2 | 27.16 | 27.16 | 27.16 | 2026-06-08 | 23.2 | 23.21 | 22.56 | 22.56 |
| 2026-08-11 | 27.2 | 27.16 | 27.16 | 27.16 | 2026-06-05 | 23.4 | 23.36 | 23.36 | 23.36 |
| 2026-08-10 | 27.2 | 27.16 | 27.16 | 27.16 | 2026-06-04 | 22.4 | 22.35 | 22.16 | 22.28 |
| 2026-08-07 | 27.2 | 27.16 | 27.16 | 27.16 | 2026-06-03 | 23.3 | 23.27 | 22.47 | 22.47 |
| 2026-08-06 | 27.0 | 26.98 | 26.98 | 26.98 | 2026-06-02 | 23.9 | 23.89 | 23.4 | 23.52 |
| 2026-08-05 | 26.0 | 26.23 | 25.93 | 25.99 | 2026-06-01 | 23.9 | 24.01 | 23.83 | 24.01 |
| 2026-08-04 | 26.5 | 26.73 | 26.54 | 26.73 | 2026-05-29 | 21.3 | 23.15 | 21.3 | 23.15 |
| 2026-08-03 | 26.7 | 26.67 | 26.36 | 26.4 | 2026-05-28 | 21.6 | 22.09 | 21.6 | 22.09 |
| 2026-07-31 | 26.6 | 26.57 | 26.57 | 26.57 | 2026-05-27 | 22.2 | 22.18 | 21.42 | 21.79 |
| 2026-07-30 | 27.2 | 27.16 | 27.16 | 27.16 | 2026-05-26 | 23.5 | 24.38 | 23.02 | 23.02 |
| 2026-07-29 | 27.5 | 27.59 | 26.54 | 27.35 | 2026-05-22 | 24.3 | 24.26 | 24.26 | 24.26 |
| 2026-07-28 | 26.5 | 26.54 | 26.54 | 26.54 | 2026-05-21 | 22.4 | 23.4 | 22.41 | 23.4 |
| 2026-07-27 | 26.9 | 26.85 | 26.48 | 26.54 | 2026-05-20 | 24.2 | 24.2 | 22.42 | 22.42 |
| 2026-07-24 | 26.6 | 26.6 | 26.6 | 26.6 | 2026-05-19 | 23.5 | 23.46 | 23.43 | 23.46 |
| 2026-07-23 | 26.2 | 26.23 | 26.23 | 26.23 | 2026-05-18 | 23.9 | 23.89 | 23.26 | 23.83 |
| 2026-07-22 | 26.2 | 26.23 | 26.23 | 26.23 | 2026-05-15 | 24.6 | 24.57 | 24.57 | 24.57 |
| 2026-07-21 | 26.5 | 26.48 | 26.11 | 26.23 | 2026-05-14 | 25.1 | 25.06 | 25.06 | 25.06 |
| 2026-07-20 | 25.3 | 25.25 | 25.25 | 25.25 | 2026-05-13 | 25.4 | 25.4 | 25.4 | 25.4 |
| 2026-07-17 | 25.6 | 26.48 | 25.12 | 25.25 | 2026-05-12 | 25.8 | 25.83 | 25.83 | 25.83 |
| 2026-07-16 | 24.9 | 24.94 | 24.94 | 24.94 | 2026-05-11 | 25.8 | 25.83 | 25.83 | 25.83 |
| 2026-07-15 | 24.9 | 24.94 | 24.94 | 24.94 | 2026-05-08 | 25.6 | 25.65 | 25.65 | 25.65 |
| 2026-07-14 | 25.8 | 25.82 | 24.94 | 24.94 | 2026-05-07 | 25.1 | 25.43 | 25.06 | 25.43 |
| 2026-07-13 | 25.7 | 26.23 | 25.72 | 25.8 | 2026-05-06 | 26.9 | 26.85 | 26.85 | 26.85 |
| 2026-07-10 | 25.6 | 25.74 | 25.56 | 25.74 | 2026-05-05 | 26.9 | 26.85 | 26.85 | 26.85 |
| 2026-07-09 | 24.7 | 24.69 | 24.69 | 24.69 | 2026-05-04 | 26.9 | 26.85 | 26.85 | 26.85 |
| 2026-07-08 | 25.2 | 25.19 | 25.19 | 25.19 | 2026-05-01 | 26.8 | 26.79 | 26.54 | 26.54 |
| 2026-07-07 | 25.7 | 25.74 | 24.73 | 24.95 | 2026-04-30 | 26.3 | 26.25 | 26.25 | 26.25 |
| 2026-07-06 | 25.9 | 25.93 | 25.86 | 25.86 | 2026-04-29 | 26.4 | 26.36 | 26.25 | 26.25 |
| 2026-07-02 | 24.4 | 24.38 | 23.7 | 23.7 | 2026-04-28 | 26.4 | 26.45 | 26.45 | 26.45 |
| 2026-07-01 | 21.9 | 21.91 | 21.91 | 21.91 | 2026-04-27 | 28.0 | 28.02 | 28.02 | 28.02 |
| 2026-06-30 | 21.4 | 21.66 | 21.42 | 21.66 | 2026-04-24 | 27.2 | 28.02 | 27.16 | 28.02 |
| 2026-06-29 | 22.1 | 22.16 | 21.98 | 22.12 | 2026-04-23 | 28.5 | 28.48 | 27.04 | 27.04 |
| 2026-06-26 | 21.1 | 21.53 | 20.25 | 20.25 | 2026-04-22 | 27.2 | 27.16 | 27.16 | 27.16 |
| 2026-06-25 | 20.9 | 20.95 | 20.12 | 20.43 | 2026-04-21 | 27.6 | 27.59 | 27.16 | 27.16 |
| 2026-06-24 | 21.8 | 21.79 | 21.5 | 21.57 | 2026-04-20 | 28.4 | 28.4 | 28.4 | 28.4 |
| 2026-06-23 | 21.5 | 21.72 | 21.23 | 21.23 | 2026-04-17 | 28.4 | 28.4 | 27.78 | 28.4 |
| 2026-06-22 | 21.3 | 21.3 | 20.74 | 21.11 | 2026-04-16 | 28.8 | 28.83 | 28.83 | 28.83 |
| 2026-06-18 | 21.2 | 21.31 | 20.99 | 21.3 | 2026-04-15 | 28.9 | 29.75 | 28.93 | 29.75 |
| 2026-06-17 | 22.0 | 22.02 | 21.02 | 21.23 | 2026-04-14 | 28.6 | 28.58 | 28.58 | 28.58 |
| 2026-06-16 | 22.4 | 22.43 | 22.16 | 22.35 | 2026-04-13 | 28.2 | 28.89 | 28.15 | 28.46 |
| 2026-06-15 | 23.0 | 22.96 | 22.84 | 22.84 | 2026-04-10 | 29.4 | 29.41 | 28.83 | 28.83 |
| 2026-06-12 | 22.4 | 22.35 | 22.35 | 22.35 | 2026-04-09 | 28.7 | 28.7 | 28.7 | 28.7 |
| 2026-06-11 | 22.3 | 22.47 | 22.28 | 22.35 | 2026-04-08 | 28.9 | 28.89 | 28.89 | 28.89 |
| 2026-06-10 | 22.8 | 22.84 | 22.25 | 22.25 | 2026-04-07 | 31.0 | 31.01 | 31.01 | 31.01 |
CSPC Pharmaceutical Group Ltd (CSPCY) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
CSPC Pharmaceutical Group Ltd
ISIN : US12591J2078
Share Class Description:
CSPCY: ADRTotal Employee Number:
19,700Compare
Compare
Traded in other countries / regions
01093.Hong KongCVG.GermanyCHJTF.USA1093N.Mexico IPO Date
2018-04-03Description
CSPC Pharmaceutical Group LTD is engaged in the manufacture and sale of pharmaceutical products. The group's segments include: Finished drugs, consisting research and development, manufacture and sale of pharmaceutical products and license fee income; Bulk products, that manufacture and sale of vitamin C, and antibiotic products in bulk powder form; and Functional food and others, that manufacture and sale of functional food products (including caffeine food additives, anhydrous glucose, acarbose and vitamin C buccal tablets), provision of healthcare service and others. It derives maximum revenue from Finished Products segments. Geographically, the company operates in Chinese Mainland, which Chinese Mainland generates maximum revenue; Other Asian regions; Europe; North America; and Others.